Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 0.76% is 14% below its 5-year average of 0.88%, around the middle of its 5-year range (-2.80%–5.48%).
154.68% above its 12-month average of -1.39%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.48%.
RETURN ON ASSETS (ROA)
0.76%
RETURN ON ASSETS (ROA) AVG TTM
-1.39%
RETURN ON ASSETS (ROA) AVG 3Y
-1.28%
RETURN ON ASSETS (ROA) AVG 5Y
0.88%
RETURN ON ASSETS (ROA) AVG 10Y
3.07%
RETURN ON ASSETS (ROA) AVG 15Y
4.91%
RETURN ON ASSETS (ROA) AVG 20Y
6.42%
CURRENT VS TTM AVG
+154.68%
CURRENT VS 3Y AVG
+159.49%
CURRENT VS 5Y AVG
-13.96%
CURRENT VS 10Y AVG
-75.27%
CURRENT VS 15Y AVG
-84.53%
CURRENT VS 20Y AVG
-88.17%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+102.36%
vs the sector median at left
ICU Medical, Inc.
Market Cap
$3.96B
Return on Assets (ROA)
0.76%
TTM Avg
-1.39%
3Y Avg
-1.28%
5Y Avg
0.88%
Market Cap
$4.02B
Return on Assets (ROA)
-29.57%
TTM Avg
-41.63%
3Y Avg
-37.55%
5Y Avg
-32.14%
Market Cap
$4.06B
Return on Assets (ROA)
-12.59%
TTM Avg
-11.38%
3Y Avg
-5.58%
5Y Avg
0.19%
Market Cap
$3.84B
Return on Assets (ROA)
-62.27%
TTM Avg
-56.63%
3Y Avg
-50.24%
5Y Avg
-125.83%
Market Cap
$4.12B
Return on Assets (ROA)
7.14%
TTM Avg
-3.40%
3Y Avg
-2.46%
5Y Avg
-5.09%
Market Cap
$4.26B
Return on Assets (ROA)
-41.11%
TTM Avg
-28.92%
3Y Avg
-26.43%
5Y Avg
-22.29%
Market Cap
$4.34B
Return on Assets (ROA)
-9.97%
TTM Avg
-20.59%
3Y Avg
-24.65%
5Y Avg
-22.36%
Market Cap
$3.57B
Return on Assets (ROA)
-11.52%
TTM Avg
-33.33%
3Y Avg
-29.18%
5Y Avg
-25.57%
Market Cap
$3.54B
Return on Assets (ROA)
7.70%
TTM Avg
3.29%
3Y Avg
-0.81%
5Y Avg
-2.88%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ICU Medical, Inc. (ICUI) | $3.96B | 0.76% | -1.39% | -1.28% | 0.88% |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.02B | -29.57% | -41.63% | -37.55% | -32.14% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.06B | -12.59% | -11.38% | -5.58% | 0.19% |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.84B | -62.27% | -56.63% | -50.24% | -125.83% |
| LivaNova PLC (LIVN)vs › | $4.12B | 7.14% | -3.40% | -2.46% | -5.09% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.26B | -41.11% | -28.92% | -26.43% | -22.29% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.34B | -9.97% | -20.59% | -24.65% | -22.36% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | -11.52% | -33.33% | -29.18% | -25.57% |
| Veracyte, Inc. (VCYT)vs › | $3.54B | 7.70% | 3.29% | -0.81% | -2.88% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.54B | -1.28% | -8.27% | -17.73% | -16.90% |
ROA
0.8%
ROE
1.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 0.02% |
| 2024-12-31 | -2.80% |
| 2023-12-31 | -0.68% |
| 2022-12-31 | -1.65% |
| 2021-12-31 | 5.48% |
| 2020-12-31 | 4.93% |
| 2019-12-31 | 5.97% |
| 2018-12-31 | 1.82% |
| 2017-12-31 | 4.59% |
| 2016-12-31 | 8.95% |
| 2015-12-31 | 7.18% |
| 2014-12-31 | 4.87% |
| 2013-12-31 | 8.09% |
| 2012-12-31 | 9.63% |
| 2011-12-31 | 12.28% |
| 2010-12-31 | 9.91% |
| 2009-12-31 | 8.59% |
| 2008-12-31 | 8.57% |
| 2007-12-31 | 9.51% |
| 2006-12-31 | 10.51% |
| 2005-12-31 | 9.91% |
| 2004-12-31 | 3.03% |
| 2003-12-31 | 13.57% |
| 2002-12-31 | 12.53% |
| 2001-12-31 | 13.11% |
| 2000-12-31 | 12.69% |
| 1999-12-31 | 12.47% |
| 1998-12-31 | 11.54% |
| 1997-12-31 | 11.13% |
| 1996-12-31 | 9.48% |
